Online-Ressource
Rockefeller University Press
;
2021
In:
Journal of Experimental Medicine Vol. 218, No. 9 ( 2021-09-06)
In:
Journal of Experimental Medicine, Rockefeller University Press, Vol. 218, No. 9 ( 2021-09-06)
Kurzfassung:
The NS1 protein of flaviviruses is taking center stage. Recent work has made it an attractive target for development of vaccines and immunotherapeutics. Cavazzoni and colleagues (2021. J. Exp. Med.https://doi.org/10.1084/jem.20210580) now reveal a dark side to NS1, linking it to the development of self-reactive antibodies.
Materialart:
Online-Ressource
ISSN:
0022-1007
,
1540-9538
DOI:
10.1084/jem.20211348
Sprache:
Englisch
Verlag:
Rockefeller University Press
Publikationsdatum:
2021
ZDB Id:
1477240-1
| Bibliothek |
Standort |
Signatur |
Band/Heft/Jahr |
Verfügbarkeit |
